C7ORF13 antibody (AA 1-100) (Biotin)

Catalog No. ABIN1699928

Product Details anti-C7ORF13 Antibody (Biotin)

Target: C7ORF13 (Chromosome 7 Open Reading Frame 13 (C7ORF13))

Binding Specificity: AA 1-100

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This C7ORF13 antibody is conjugated to Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Predicted Reactivity: Human

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C7orf13

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C for 12 months.

Expiry Date: 12 months

Target Details for C7ORF13

Target: C7ORF13 (Chromosome 7 Open Reading Frame 13 (C7ORF13))

Alternative Name: C7orf13 (C7ORF13 Products)

Synonyms: MY040 antibody, chromosome 7 open reading frame 13 antibody, C7orf13 antibody

Background:

Synonyms: Chromosome 7 open reading frame 13, MY040, Uncharacterized protein C7orf13,CG013_HUMAN.

Background: Chromosome 7 is about 158 milllion bases long, encodes over 1000 genes and makes up about 5 % of the human genome. Chromosome 7 has been linked to Osteogenesis imperfecta, Pendred syndrome, Lissencephaly, Citrullinemia and Shwachman-Diamond syndrome. The deletion of a portion of the q arm of chromosome 7 is associated with Williams-Beuren syndrome, a condition characterized by mild mental retardation, an unusual comfort and friendliness with strangers and an elfin appearance. Deletions of portions of the q arm of chromosome 7 are also seen in a number of myeloid disorders including cases of acute myelogenous leukemia and myelodysplasia. The C7orf13 gene product has been provisionally designated C7orf13 pending further characterization.